The CRO industry experienced sudden growth in 2020 due to the surge in R&D efforts related to COVID-19 therapies and vaccines. This research highlights the major global CROs, new growth patterns, influences and challenges across regions, and clinical development phases.
Get an overview of the digital pathology industry, including a detailed segment analysis, the various promising and emerging business models that are likely to dominate this sector, growth prospects, revenue forecast, and the opportunities from using AI in image analysis.
How are industry dynamics affecting the virtual care sector? What is the five-year revenue outlook for this sector and its major segments? What are the major drivers and challenges for the virtual care segments to achieve their enormous potential? Read this research to find out.
1. Time for change
2021 will (fingers crossed) go down in history as the year the world started to take climate change seriously. In April, the UK and Chinese governments announced ambitious goals of achieving carbon zero by 2050 and 2060 respectively. America plans to achieve a 50-52% reduction from 2005 levels in economy-wide net greenhouse gas pollution by 2030.
In the corporate world, high-tech businesses such as Microsoft, Apple and Novo Nordisk and service companies such as EY, Sky and KPMG have set their sights on achieving carbon zero by 2030. The more energy intensive industries including manufacturers (Cemex, Holcim and Tetrapak), oil and gas firms (BP, Shell and Total) and airline companies (BA, American Airlines and Japan Airlines) plan to reach this target by 2050.
Schedule a consultation with an industry expert at no charge by contacting us at myfrost@frost.com. We are taking unprecedented action to make our team available to help you cut through the media and politics to get factual one-to-one guidance for the issues and opportunities that matter most to your business.
Innovative ROI Streams and Patient-centric Virtual Care Approaches Powering the Healthcare Industry
Read more Request Info
Smartphone-based Saliva Testing and Self-monitoring of Blood Glucose Driving the Digital POCT Sector
Read more Request Info
Growth Prospects Powering the Digital Operating Room Sector in the United States and Western Europe
Read more Request Info
US Real-world Evidence IT Solutions Sector: Shifting Spotlight Intensifies Growth
Read more Request Info
Emerging Growth Opportunities in the Global Magnetic Resonance Imaging (MRI) Sector
Read more Request Info
Growth Opportunity Analysis of the North American Clinical Documentation Improvement Sector
Read more Request Info
Advanced Analytics and Integrated Sensors Boost US and Western European Patient Safety Solutions
Read more Request Info
Cloud Services Propel Growth of Laboratory Information Management Systems in the US and EU
Read more Request InfoAs the biologics Contract Development and Manufacturing Organization (CDMO) market expands at double-digit rates, Thermo Fisher Scientific (TMO) is doubling down on its portfolio again, after acquiring Henogen SA (viral vector manufacturer) and Mesa Biotech, Inc earlier this year.PPD’s acquisition will boost TMO’s position in the CDMO market.
Read more
As professionals, our careers are often assessed on our ability to identify critical technology growth opportunities and mitigate the inherent risk associated with our choices. One important consideration is how these technologies converge to create unique technology profiles that previously would not have been considered. Our Top 50 Platform is a highly effective, low-risk tool that can be added to your toolkit to enhance your decision-making by being more thorough and introducing elements of out-of-the-box perspectives that are necessary in today’s rapid and, yes, hostile technology growth environment.
Read more
While there is some light at the end of the tunnel, thanks to the presence of COVID-19 vaccines, the job is far from complete. The distribution of the vaccine has its own challenges. However, India has prior experience with large-scale vaccination programs. India’s Universal Immunization Programme (UIP), which immunizes approximately 26.7 million new-borns and 29 million pregnant women annually against 12 vaccine-preventable diseases, is one of the largest public health programs globally.
Read more
Frost & Sullivan’s recent analysis finds that the emergence of the anytime-anywhere care concept with the COVID-19 outbreak has transformed the healthcare sector worldwide, resulting in a surge in demand for digital health applications—especially telehealth and remote patient monitoring. Vendors’ need to redefine their visions and strategies to align with the new normal will be a key factor that will define the global healthcare market in the coming years. In an optimistic scenario, the total healthcare market—pharmaceuticals and biotechnology, in-vitro diagnostics, advanced medical technologies, medical imaging and informatics, and digital health—is estimated to hit over $2.6 trillion by 2025, growing at a compound annual growth rate of 6.3%.
Frost & Sullivan’s recent analysis, Innovative Business Models Powering the Telehealth Market in Europe, finds that the severe impact of COVID-19 on the healthcare sector across Europe catapulted the use of telehealth. It ensured efficient access to essential healthcare services for patients with chronic conditions or those requiring acute and urgent care during the pandemic. The healthcare sector shift to the “anytime and anywhere” model in response to the pandemic resulted in a massive surge in the region’s telehealth market. By 2026, the booming market is estimated to witness more than a four-and-a-half-fold growth, garnering $20.7 billion revenue from $4.41 billion in 2019, up at a strong compound annual growth rate (CAGR) of 29.4%.
Frost & Sullivan’s recent analysis finds that the emergence of new technologies such as artificial intelligence (AI) and the cloud, evolving clinical and administrative/operational needs, and the introduction of new policies and regulations will boost the global medical imaging informatics market. This market—which comprises radiology IT solutions, ancillary IT solutions, other departmental IT solutions such as cardiovascular information systems, and enterprise imaging IT solutions—is estimated to hit $10.4 billion by 2025 from $8.5 billion in 2019, registering a compound annual growth rate (CAGR) of 3.5%.
Read more
